Abstract:Cancer progression remains a significant clinical challenge. Phenotypic adaptation by tumor cells results in disease heterogeneity, which drives treatment resistance and immune escape. T cell immunotherapy, while effective at treating some cancer subtypes, can also fail due to limits on tumor immunogenicity or T cell recognition. For example, one potential contributor to immune escape involves the density and alignment of the extracellular matrix (ECM) surrounding tumors, also known as Tumor-Associated Collagen Signature (TACS). However, the specific mechanisms by which aligned fibers contribute to decreased patient survival rates have not yet been decoupled. Here, we developed our EVO-ACT (EVOlutionary Agent-based Cancer T cell interaction) model to study how TACS affects tumor evolution and dynamic tumor-T cell interactions. We identified a variety of TACS-specific dynamical features that influence T cell infiltration, cancer immunoediting, and ultimate immune escape. Our model demonstrates how TACS and phenotypic adaptation together explain overall survival trends in breast cancer.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore how the structure of the extracellular matrix (ECM), especially the tumor - associated collagen signature (TACS), affects tumor immune escape and elimination. Specifically, the study aims to reveal the role of TACS in tumor evolution and how it shapes the dynamic interaction between tumors and T - cells, thereby affecting patient survival rates. ### Core issues of the paper 1. **The impact of TACS on tumor immune escape**: - TACS (Tumor - Associated Collagen Signature) refers to the arrangement of the extracellular matrix (ECM) around the tumor, including randomly arranged fibers (TACS1), annularly arranged fibers (TACS2), and radially arranged fibers (TACS3). How these different arrangements affect the tumor's immune recognition and escape mechanisms is not yet fully understood. 2. **The relationship between TACS and tumor evolution**: - The researchers developed an agent - based evolutionary model, EVO - ACT, to simulate how TACS affects the tumor's evolutionary process and the dynamic interaction between T - cells and tumor cells. Through this model, the researchers hope to understand how TACS affects T - cell infiltration, cancer cell immuno - editing, and ultimately immune escape. 3. **The impact of TACS on patient survival rates**: - Clinical observations have found that the presence of TACS is associated with lower patient survival rates, but the specific mechanism is not clear. The researchers hope to use the model to reveal how TACS changes the patient's survival trend by affecting the immune response. ### Main hypotheses and methods - **Hypothesis**: Different arrangements of TACS will affect the migration efficiency of T - cells and the immune escape ability of tumor cells, and thus affect the patient's survival rate. - **Method**: The researchers used an agent - based evolutionary model (EVO - ACT) to simulate the dynamic behaviors of tumor cells and T - cells under different TACS conditions. By adjusting parameters in the model, such as fiber arrangement, T - cell receptor (TCR) diversity, etc., the researchers were able to quantify the impact of TACS on tumor evolution and the immune response. ### Key findings 1. **TACS3 promotes efficient T - cell infiltration**: - The model results show that the T - cell migration efficiency is the highest under TACS3 conditions, followed by TACS1, and the lowest under TACS2. This indicates that TACS3 helps T - cells to enter the tumor core more effectively, thereby enhancing the immune response. 2. **TACS2 inhibits T - cell infiltration**: - Although TACS2 is not an absolute barrier to T - cell infiltration, it significantly reduces the T - cell migration efficiency, making it more difficult for T - cells to reach tumor cells. 3. **The role of EMT under TACS3 conditions**: - When epithelial - mesenchymal transition (EMT) was introduced, the researchers found that under TACS3 conditions, the adaptive changes of tumor cells would further reduce the patient's survival rate. EMT leads to a decrease in the immunogenicity of tumor cells and an increase in their migratory ability, thereby hindering the effective killing by T - cells. 4. **Increased expression of immune checkpoints**: - Under TACS3 conditions, tumor cells may increase the expression of PD - 1/PD - L1, further increasing the possibility of tumor escape and reducing the effectiveness of immunotherapy. ### Conclusion This study reveals the important role of TACS in tumor evolution and the immune response through the EVO - ACT model, especially how TACS3 promotes T - cell infiltration and affects tumor immune escape. However, TACS3 alone cannot fully explain the survival trends observed clinically, and other factors such as EMT and changes in immune checkpoint expression need to be combined to fully understand the mechanisms of tumor evolution and immune escape.

Distinct evolutionary patterns of tumor immune escape and elimination determined by ECM architectures

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

Immune evasion and immunotherapy resistance via TGF-beta activation of extracellular matrix genes in cancer associated fibroblasts

The regulatory roles of T helper cells in distinct extracellular matrix characterization in breast cancer

Abstract 4275: Targeting tumor extracellular matrix to improve response to therapy

Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment

Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors

The extracellular matrix in solid tumor immunotherapy

Cracking the Codes behind Cancer Cells' Immune Evasion

Extracellular matrix remodeling in the tumor immunity

Abstract 4280: Regulatory T cells contribute to tumor cell dissemination by extracellular matrix remodeling

Immune-tumor interaction dictates spatially directed evolution of esophageal squamous cell carcinoma

Bridging the Gap in Cancer Cell Behavior Against Matrix Stiffening: Insights from a Trizonal Model

3D Extracellular Matrix Regulates the Activity of T Cells and Cancer Associated Fibroblasts in Breast Cancer

Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?

The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis

Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers

Abstract 3385: Modeling evolutionary fitness in resistant cancers based on a common adaptability trait

Crosstalk between extracellular vesicles and tumor-associated macrophage in the tumor microenvironment

Abstract 5641: Tumor cell intrinsic factors in colorectal cancer immune evasion

Deciphering the dynamics of Epithelial-Mesenchymal Transition and Cancer Stem Cells in tumor progression